Search

everythinglearnresearchcommunity

for

Search:↓

Higher serum androgens contribute to male pattern baldness.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

No link found between hair loss severity and PSA levels in men.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Pig blood plasma can be used to promote human hair growth and is a good alternative to the commonly used serum additive.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

Porcine PRP can replace FBS and promote hair growth.

Dutasteride reduces DHT more effectively than finasteride.

Use gentle products and nourishing masks to keep thin hair strong and voluminous.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

The Notch signaling pathway helps in mouse hair development through a noncanonical mechanism that does not rely on RBPj or transcription.